# Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

> **NCT00359944** · PHASE2 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 171 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** AC-3933
- **DRUG:** AC-3933
- **OTHER:** Sugar Pill

## Key facts

- **NCT ID:** NCT00359944
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2013-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359944, "Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00359944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*